Approval · Notice of Compliance 14940 · 2013
DOMPERIDONE: Notice of Compliance 14940
Issued November 26, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14940
- Date
- November 26, 2013
- Company
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Modifier of upper gastroinestinal motility
- Canadian reference product
- APO-DOMPERIDONE (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOMPERIDONE | 02408937 | Approved |
Medicinal ingredients
- DOMPERIDONE MALEATE 10 MG per TAB